Extensive genetic heterogeneity in the neuroblastoma cell line NB(TU)1

International Journal of Cancer

Volumn 72, Issue 6, 1997, Pages 1070-1077

  Inoue, Akira ^a   Yokomori, Kinji ^b   Tanabe, Hideyuki ^c   Mizusawa, Hiroshi ^c   Sofuni, Toshio ^c   Hayashi, Yasuhide ^b   Tsuchida, Yoshiaki ^b   Shimatake, Hiroyuki ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME 1P; CYTOGENETICS; FEMALE; GENE REARRANGEMENT; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; KARYOTYPE; MICRONUCLEUS; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ABDOMINAL NEOPLASMS; ANIMALS; CELL LINE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; EXONS; FEMALE; GANGLIONEUROBLASTOMA; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPING; LOSS OF HETEROZYGOSITY; MICE; MICE, NUDE; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-MYC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030798493     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970917)72:6<1070::AID-IJC23>3.0.CO;2-7     Document Type: Article

References (27)

1. BETTAN-RENAUD, L., BAYLE, C., TEYSSIER, J.-R. and BERNARD, J., Stability of phenotypic and genotypic traits during the establishment of a human neuroblastoma cell line, IGR-N-835. Int. J. Cancer, 44, 460-466 (1989).
2. BRODEUR, G.M. and FONG, C.T., Molecular biology and genetics of human neuroblastoma. Cancer Genet. Cytogenet., 41, 153-174 (1989).
3. BRODEUR, G.M., SEEGER, R.C., SCHWAB, M., VARMUS, H.E. and BISHOP, J.M., Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 224, 1121-1124 (1984).
4. CASPER, J.T., TRENT, J.M., HARB, J., PIASKOWSKI, V., HELMSWORTH, M., FINLAN, J. and VON HOFF, D.D., Distinguishing characteristics of a new neuroblastoma cell line. Cancer Genet. Cytogenet., 10, 177-186 (1983).
5. CHENG, N.C., VAN ROY, N., CHAN, A., BEITSMA, M., WESTERVELD, A., SPELEMAN, F. and VERSTEEG, R., Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene, 10, 291-297 (1995).
6. CORTES, J., O'BRIEN, S., KANTARJIAN, H., CORK, A., STASS, S., FREIREICH, E.J., KEATING, M., PIERCE, S. and ESTEY, E., Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogeneous leukemias and myelodysplatic syndromes. Leukemia, 8, 2174-2178 (1994).
7. FEDER, M.K. and GILBERT, F., Clonal evolution in a human neuroblastoma. J. nat. Cancer Inst., 70, 1051-1056 (1983).
8. FOLEY, J., COHN, S.L., SALWEN, H.R., CHAGNOVICH, D., COWAN, J., MASON, K.L. and PARYSEK, L.M., Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res., 51, 6338-6345 (1991).
9. FONG, C.T., DRACOPOLI, N.C., WHITE, P.S., MERRILL, P.T., GRIFITH, R.C., HOUSMAN, D.E. and BRODEUR, G.M., Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc. nat. Acad. Sci. (Wash.), 86, 3753-3757 (1989).
10. GILBERT, F., FEDER, M., BALABAN, G., BRANGMAN, D., LURIE, D.K., PODOLSKY, R., RINALDT, V., VINKOOR, N. and WEISBAND, J., Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res., 44, 5444-5449 (1984).
11. HIYAMA, E., HIYAMA, K. and YOKOYAMA, T., Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region. Cancer Res., 51, 1946-1951 (1991).
12. HORRIGAN, S.K., WESTBROOK, C.A., KIM, A.H., BANERJEE, M., STOCK, W. and LARSON, R.A., Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood, 88, 2665-2670 (1996).
13. INOUE, A., HASAN, Z., HEMMI, H., KANDA, N., HAYASHI, Y., ISHIZAWA, T., TSUCHIDA, Y. and SHIMATAKE, H., Competitive polymerase chain reaction for the quantification of N-myc gene copy number in neuroblastoma. Tumor Biol., 17, 262-270 (1996).
14. ISCN, An international system for human cytogenetic nomenclature, F. Mitelman (ed.), S. Karger, Basel (1995).
15. LAUREYS, G., SPELEMAN, F., VERSTEEG, R., VAN DER DRIFT, P., CHAN, A., LEROY, J., FRANCKE, U., OPDENAKKER, G. and VAN ROY, N., Constitutional translocation t(1;17)(p36.31-p36.13:q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers. Oncogene, 10, 1087-1093 (1995).
16. NAKAGAWA, C., KIKUCHI, T., TSUKAHARA, T. and SHIMATAKE, H., Genomic cloning of the amplified N-myc oncogene in the homogeneously staining region of the human neuroblastoma cell line, TNB 1. J. med. Soc. Toho, 36, 199-206 (1989).
17. PETER, M., MICHON, J., VIELH, P., NEUENSCHWANDER, S., NAKAMURA, Y., SONSINO, E., ZUCKER, J.M., VERGNAUD, G., THOMAS, G. and DELATTRE, O., PCR assay for chromosome 1p deletion in small neuroblastoma samples. Int. J. Cancer, 52, 544-548 (1992).
18. RUSSELL, J., WHELDON, T.E. and STANTON, P., A radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. Cancer Res., 55, 4915-4921 (1995).
19. SAWAGUCHI, S. and 16 OTHERS, Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy: a report from the study group of Japan. Cancer, 66, 1879-1887 (1990).
20. SCARPA, S., DOMINICI, C., GRAMMATICO, P., DEL PORTO, G., RASCHELL, G., CASTELLO, M., FORNI, G. and MODESTI, A., Establishment and characterization of a human neuroblastoma cell line. Int. J. Cancer, 43, 645-651 (1989).
21. SEKIGUCHI, M., OOTA, T., SAKAKIBARA, K., INUI, N. and FUJII, G., Establishment and characterization of a human neuroblastoma cell line in tissue culture. Jpn. J. exp. Med., 49, 67-83 (1979).
22. SHILOH, Y., KORF, B., KOHL, N.E., SAKAI, K., BRODEUR, G.M., HARRIS, P., KANDA, N., SEEGER, R.C., ALT, F. and LATT, S.A., Amplification and rearrangement of DNA sequences from the chromosomal region 2p24 in human neuroblastomas. Cancer Res., 46, 5297-5301 (1986).
23. SUGIO, K., NAKAGAWARA, A. and SASAZUKI, T., Association of expression between N-myc gene and major histocompatibility complex class I gene in surgically resected human neuroblastoma. Cancer, 67, 1384-1388 (1991).
24. TAKEDA, O., HOMMA, C., MASEKI, N., SAKURAI, M., KANDA, N., SCHWAB, M., NAKAMURA, Y. and KANEKO, Y., There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer, 10, 30-39 (1994).
25. TANABE, H., ISHIDA, T., UEDA, S., SOFUNI, T. and MIZUSAWA, H., Regional assignment of the human immunoglobulin processed pseudogene C-epsilon 3 (IGHEP2) to 9p24.2-p24.1 by fluorescence in situ hybridization. Cytogenet. Cell Genet., 66, 93-95 (1994).
26. TUMILOWICZ, J.J., NICHOLS, W.W., CHOLON, J.J. and GREENE, A.E., Definition of a continuous human cell line derived from neuroblastoma. Cancer Res., 30, 2110-2118 (1970).
27. WADA, R.K., SEEGER, R.C., REYNOLDS, C.P., ALLOOGIAMENTO, T., YAMASHIRO, J.M., RULAND, C., BLACK, A.C. and ROSENBLATT, J.D., Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells. Oncogene, 7, 711-717 (1992).